Division of Geriatric Medicine

Department of Medicine

(FEBRUARY 28, 2023) James Gerson, M.D., assistant professor of medicine and director of the CAR T-Cell Program, spoke to the Press-Republican about the promising cancer treatment called CAR T-cell therapy that is now available at the UVM Cancer Center.

The University of Vermont’s Larner College of Medicine features some of the world’s foremost cardiovascular researchers, experts in cardiovascular disease risk factors, thrombosis, atherosclerosis, stroke, and heart failure. the science shared by early-career investigators at the Cardiovascular Research Institute of Vermont’s fourth annual Viridis Montis Challenge, it was apparent that the institution’s reputation and legacy in the field of cardiovascular research will continue to have a global impact.

The University of Vermont Cancer Center now offers a novel, highly effective form of cancer treatment called CAR T-cell therapy, and recently began treating patients. The Cancer Center is the only health care institution in Vermont and northern New York to provide the treatment.

A new study published in JAMA Cardiology by UVM cardiovascular medicine fellow Margaret Infeld, M.D., M.S., and colleagues found evidence that by implementing a tailored acceleration of heart rates, they could reduce congestion and improve the circulation of blood in heart failure patients with "stiff" hearts.

Randall F. Holcombe, M.D., M.B.A., director of the UVM Cancer Center and chief of the Division of Hematology and Oncology in the Department of Medicine, has been appointed as associate dean for cancer programs at the UVM Larner College of Medicine.

(FEBRUARY 17, 2023) Diego Adrianzen Herrera, M.D., assistant professor of medicine, commented to Medscape on a study of postremission therapy in patients with intermediate-risk acute myeloid leukemia (AML) that was published online in JAMA Oncology.

Sherrie Khadanga, M.D., M.S., assistant professor of medicine at UVM's Larner College of Medicine and assistant director of cardiac rehabilitation at the UVM Medical Center, was recently featured in a UVM Health Network HealthSource blog post titled "Women Find Strength with Cardiac Rehab" that focused on how High-Intensity Interval Training (HIIT) exercise can help women's recovery after a cardiac event.

(FEBRUARY 11, 2023) Mary Cushman, M.D., M.Sc., professor of medicine and director of the thrombosis and hemostasis program at the UVM Medical Center, recently spoke with The American Journal of Managed Care about racial trends in pulmonary embolism treatment and potential improvements compared with pre-pandemic trends.

(FEBRUARY 9, 2023) Anne Dixon, M.A., B.M.B.Ch., professor of medicine, commented to The (Lowell, Massachusetts) Sun about a new study led by the Harvard T.H. Chan School of Public Health that found that a healthy lifestyle could lower the risk of long COVID.

(FEBRUARY 8, 2023) A randomized trial conducted by nephrologist Richard Solomon, M.D., professor of medicine, and colleagues found that a machine-learning intervention provided a higher level of safety during cardiac catheterization, lowering the chances of acute kidney injury (AKI), according to Health IT Analytics.

(FEBRUARY 7, 2023) Results of a study by Margaret Infeld, M.D., clinical cardiac electrophysiology fellow and clinical instructor in the Department of Medicine; cardiologist Markus Meyer, M.D., Ph.D., adjunct associate professor of medicine; and colleagues support heart rate modulation as a therapeutic intervention in HFpEF, according to HealthDay News.

The Cardiovascular Research Institute of Vermont held its 4th Annual Viridis Montis Early Career Investigator Challenge on February 1, 2023, and Toishi Sharma, MBBS, cardiovascular disease fellow in the Department of Medicine, was selected as the winner.

(JANUARY 25, 2023) In an article published by the Annie Lab newsroom, Gilman Allen, M.D., professor of medicine, disputed a claim in a January 2023 Twitter video highlighting findings from a “brand-new” Japanese study demonstrating that “masking breeds dangerous bacteria and fungi” and therefore justifies ending mandatory mask wearing.

(JANUARY 23, 2023) Despite some higher COVID transmission rates in certain areas, infectious disease specialist Tim Lahey, M.D., M.M.Sc., professor of medicine, told WCAX that the overall number of COVID cases in Vermont remains low.

(JANUARY 18, 2023) David Kaminsky, M.D., professor of medicine, a pulmonologist and critical care physician who routinely sees patients with long COVID symptoms, was quoted in a Seven Days story about the use of hyperbaric oxygen therapy (HBOT) for patients suffering from so-called long COVID.

(JANUARY 17, 2023) A recent study by Katharine L. Cheung, M.D., Ph.D., assistant professor of medicine, and colleagues shows that residence in the so-called stroke belt of the southeastern United States is an independent risk factor for incident chronic kidney disease (CKD), Renal & Urology News reported.

(JANUARY 16, 2023) Martin Keller, M.D., associate professor of pediatric surgery, is a co-author of a study that found increased pediatric firearm injury and death rates tied to the COVID pandemic, HealthDay News reported.

(JANUARY 6, 2023) A recent study led by Mary Cushman, M.D., M.Sc., professor of medicine and of pathology and laboratory medicine, found that people with blood type AB are 82 percent more likely to experience thinking and memory impairments that can lead to dementia, World Today News reported.

(JANUARY 3, 2023) Infectious disease specialist Tim Lahey, M.D., M.M.Sc., professor of medicine, was quoted in a story on WVNY-TV ABC22 about the latest COVID variant spreading in Vermont and New Hampshire.

(DECEMBER 25, 2022) Research by Mary Cushman, M.D., M.Sc., professor of medicine, and colleagues found inequities in treatments and outcomes for pulmonary embolism, The ASCO Post reports.